Marianne Schepers

Marianne Schepers is an active researcher in nuclear medicine and molecular imaging with multiple publications between 2014-2016. Her work focuses on receptor occupancy studies, particularly related to sigma-1 receptors, and radiopharmaceutical development.

Her research interests span Nuclear Medicine, Molecular Imaging, and Neuropharmacology. Schepers has made significant contributions to understanding sigma-1 receptor occupancy and its relationship to cognitive function, particularly in the context of sleep deprivation and memory. She has also developed improved methods for GMP-compliant production of radiopharmaceuticals.

Analysis of her publications reveals a strong focus on receptor occupancy measurement techniques, particularly using PET imaging with radiotracers like (11)C-SA4503 and fluorine-18 labeled compounds. Her work bridges pharmacology, neuroscience, and medical imaging, with applications in understanding neurological conditions and developing therapeutic approaches.

• Specializes in sigma-1 receptor pharmacology
• Develops GMP-compliant radiopharmaceutical production methods
• Studies receptor occupancy relationships with cognitive effects
• Works with fluorine-18 and carbon-11 labeled tracers

Schepers maintains active research collaborations with prominent scientists in the nuclear medicine field. Her work contributes to UN Sustainable Development Goals related to good health and well-being through advancements in medical imaging and neurological research. The fingerprint analysis of her research shows strong connections to Pharmacology, Toxicology, Pharmaceutical Science, and Neuroscience, with particular expertise in Sigma-1 Opiate Receptor, Cutamesine, DOPA, Receptor Occupancy, and Fluorine-18 tracer development.